Literature DB >> 23073864

Cardioversion in atrial fibrillation. Focus on recent-onset atrial fibrillation.

Andrea Tampieri1, Anna Maria Rusconi, Tiziano Lenzi.   

Abstract

Atrial fibrillation is the most common sustained arrhythmia encountered in clinical practice. Its prevalence is rising due to an increasing elderly population and the improvement in management of life-threatening diseases such as myocardial infarction and heart failure. Over the past few years effective non-pharmacological treatments, new antiarrhythmics drugs, and anticoagulants have been introduced. Regardless of rate-control or rhythm control strategy, adequate stroke prevention still remains a cornerstone in the treatment of this arrhythmia. This review aims to illustrate the main practical issues in the management of atrial fibrillation, focusing on patients with recent-onset and hemodynamically stable atrial fibrillation.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23073864     DOI： 10.1007/s11739-012-0863-0

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


  69 in total

1.  Association of the Ottawa Aggressive Protocol with rapid discharge of emergency department patients with recent-onset atrial fibrillation or flutter.

Authors:  Ian G Stiell; Catherine M Clement; Jeffrey J Perry; Christian Vaillancourt; Cheryl Symington; Garth Dickinson; David Birnie; Martin S Green
Journal:  CJEM       Date:  2010-05       Impact factor: 2.410

2.  A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study.

Authors:  Jean-Yves Le Heuzey; Gaetano M De Ferrari; David Radzik; Massimo Santini; Junren Zhu; Jean-Marc Davy
Journal:  J Cardiovasc Electrophysiol       Date:  2010-04-06

3.  A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation.

Authors:  A John Camm; Alessandro Capucci; Stefan H Hohnloser; Christian Torp-Pedersen; Isabelle C Van Gelder; Brian Mangal; Gregory Beatch
Journal:  J Am Coll Cardiol       Date:  2011-01-18       Impact factor: 24.094

4.  Disparities in management of new-onset atrial fibrillation in the emergency department despite adherence to the current guidelines: data from a large metropolitan area.

Authors:  Francesco Buccelletti; Salvatore Di Somma; Alberto Galante; Francesco Pugliese; Filippo Alegiani; Giuliano Bertazzoni; Nicolò Gentiloni Silveri; Jacopo M Legramante; Francesco Franceschi
Journal:  Intern Emerg Med       Date:  2011-02-13       Impact factor: 3.397

5.  Rising rates of hospital admissions for atrial fibrillation.

Authors:  Jens Friberg; Pernille Buch; Henrik Scharling; Niels Gadsbphioll; Gorm B Jensen
Journal:  Epidemiology       Date:  2003-11       Impact factor: 4.822

6.  Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.

Authors:  Jonathan S Steinberg; Ara Sadaniantz; Jack Kron; Andrew Krahn; D Marty Denny; James Daubert; W Barton Campbell; Edward Havranek; Katherine Murray; Brian Olshansky; Gearoid O'Neill; Magdi Sami; Stanley Schmidt; Randle Storm; Miguel Zabalgoitia; John Miller; Mary Chandler; Elaine M Nasco; H Leon Greene
Journal:  Circulation       Date:  2004-03-29       Impact factor: 29.690

7.  Biphasic energy selection for transthoracic cardioversion of atrial fibrillation. The BEST AF Trial.

Authors:  B M Glover; S J Walsh; C J McCann; M J Moore; G Manoharan; G W N Dalzell; A McAllister; B McClements; D J McEneaney; T G Trouton; T P Mathew; A A J Adgey
Journal:  Heart       Date:  2007-06-25       Impact factor: 5.994

8.  Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset.

Authors:  Johann Reisinger; Edmund Gatterer; Wolfgang Lang; Thetis Vanicek; Geza Eisserer; Theresia Bachleitner; Christopher Niemeth; Friedrich Aicher; Wilhelm Grander; Georg Heinze; Peter Kühn; Peter Siostrzonek
Journal:  Eur Heart J       Date:  2004-08       Impact factor: 29.983

9.  High-density mapping of electrically induced atrial fibrillation in humans.

Authors:  K T Konings; C J Kirchhof; J R Smeets; H J Wellens; O C Penn; M A Allessie
Journal:  Circulation       Date:  1994-04       Impact factor: 29.690

10.  Addressing the management of atrial fibrillation - a systematic review of the role of dronedarone.

Authors:  Gian Marco Podda; Giovanni Casazza; Francesco Casella; Franca Dipaola; Emanuela Scannella; Ludovica Tagliabue
Journal:  Int J Gen Med       Date:  2012-05-28
View more
  1 in total

1.  Efficacy and safety in pharmacological cardioversion of recent-onset atrial fibrillation: a propensity score matching to compare amiodarone vs class IC antiarrhythmic drugs.

Authors:  Antonio Bonora; Gianni Turcato; Elena Franchi; Gabriele Taioli; Alice Dilda; Germana Zerman; Antonio Maccagnani; Claudio Pistorelli; Oliviero Olivieri
Journal:  Intern Emerg Med       Date:  2016-07-06       Impact factor: 3.397
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.